Humana Inc. $HUM Shares Bought by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. boosted its stake in shares of Humana Inc. (NYSE:HUM) by 152.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 6,164 shares of the insurance provider’s stock after purchasing an additional 3,718 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Humana were worth $1,579,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. Pzena Investment Management LLC boosted its position in Humana by 1.0% during the fourth quarter. Pzena Investment Management LLC now owns 4,072,208 shares of the insurance provider’s stock worth $1,043,015,000 after purchasing an additional 41,125 shares in the last quarter. Diamond Hill Capital Management Inc. raised its position in Humana by 0.7% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 79,575 shares of the insurance provider’s stock worth $20,382,000 after acquiring an additional 586 shares during the last quarter. Goldenstone Wealth Management LLC acquired a new position in Humana during the fourth quarter worth about $343,000. Global Retirement Partners LLC raised its position in Humana by 154.7% during the fourth quarter. Global Retirement Partners LLC now owns 1,034 shares of the insurance provider’s stock worth $265,000 after acquiring an additional 628 shares during the last quarter. Finally, Leonteq Securities AG acquired a new position in Humana during the fourth quarter worth about $735,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Price Performance

Humana stock opened at $307.13 on Thursday. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $315.66. The stock has a market capitalization of $36.87 billion, a P/E ratio of 32.85, a P/E/G ratio of 2.19 and a beta of 0.68. The firm’s 50-day moving average is $226.50 and its two-hundred day moving average is $228.10. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. During the same quarter in the prior year, the company posted $11.58 EPS. The business’s revenue for the quarter was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. Equities analysts predict that Humana Inc. will post 9.01 earnings per share for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s dividend payout ratio is currently 37.86%.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on HUM shares. Deutsche Bank Aktiengesellschaft cut shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, May 20th. Wells Fargo & Company downgraded Humana from a “cautious” rating to a “reduce” rating in a research report on Wednesday, May 20th. Weiss Ratings reissued a “sell (d+)” rating on shares of Humana in a research report on Tuesday, April 21st. William Blair initiated coverage on Humana in a research report on Wednesday, May 20th. They set an “outperform” rating for the company. Finally, Barclays raised their price target on Humana from $180.00 to $344.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Nine equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $270.48.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.